Security
Omada Health, Inc. Common Stock · OMDA
OMDANASDAQCommon stockCurrentCIK 1611115Updated Nov 14, 2026
OMDA price & chart
Loading TradingView…
NASDAQ:OMDA on TradingView ↗In the news
Seeking Alpha
Omada Health, Inc. (OMDA) Q3 2026 Earnings Call Transcript ↗
Omada Health Shows Promising Growth But I Question The Moat ↗
Omada Health, Inc. (OMDA) Analyst/Investor Day Transcript ↗
SEC disclosures
Omada Health, Inc. files 8-K: Material Event ↗
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 |
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| AssetsUSD | 287,469,000Source | — | 328,222,000Source | 302,971,000Source | — | 302,798,000Source | — | 305,406,000Source | 150,892,000Source |
| Property, Plant and Equipment, NetUSD | 7,537,000Source | — | 9,098,000Source | 6,484,000Source | — | 8,455,000Source | — | 7,942,000Source | 5,625,000Source |
| GoodwillUSD | 13,240,000Source | — | 13,240,000Source | 13,240,000Source | — | 13,240,000Source | — | 13,240,000Source | 13,240,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 2,853,000Source | — | 1,536,000Source | 3,291,000Source | — | 1,975,000Source | — | 2,414,000Source | 4,263,000Source |
| Current assets: | |||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 198,627,000Source | — | 221,712,000Source | 223,146,000Source | — | 211,765,000Source | — | 222,036,000Source | 76,392,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 41,446,000Source | — | 56,573,000Source | 33,287,000Source | — | 39,985,000Source | — | 34,585,000Source | 23,417,000Source |
| Inventory, NetUSD | 3,148,000Source | — | 4,119,000Source | 3,469,000Source | — | 3,831,000Source | — | 4,486,000Source | 3,296,000Source |
| Assets, CurrentUSD | 254,898,000Source | — | 294,911,000Source | 271,105,000Source | — | 269,427,000Source | — | 272,934,000Source | 113,059,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 8,449,000Source | — | 8,548,000Source | 7,750,000Source | — | 9,827,000Source | — | 8,288,000Source | 6,937,000Source |
| Operating Lease, Right-of-Use AssetUSD | 0Source | — | — | 65,000Source | — | — | — | 0Source | 447,000Source |
| Other Assets, NoncurrentUSD | 199,000Source | — | 215,000Source | 234,000Source | — | 226,000Source | — | 165,000Source | 5,044,000Source |
| LIABILITIES AND EQUITY | |||||||||
| LiabilitiesUSD | 70,123,000Source | — | 75,483,000Source | 88,757,000Source | — | 68,680,000Source | — | 75,726,000Source | 86,261,000Source |
| Stockholders’ equity: | |||||||||
| Common Stock, Value, IssuedUSD | 58,000Source | — | 61,000Source | 56,000Source | — | 59,000Source | — | 58,000Source | 8,000Source |
| Additional Paid in CapitalUSD | 679,191,000Source | — | 707,098,000Source | 672,883,000Source | — | 693,773,000Source | — | 686,366,000Source | 59,555,000Source |
| Retained Earnings (Accumulated Deficit)USD | -461,903,000Source | — | -454,420,000Source | -458,725,000Source | — | -459,714,000Source | — | -456,744,000Source | -443,966,000Source |
| Stockholders' Equity Attributable to ParentUSD | 217,346,000Source | -379,772,000Source | 252,739,000Source | 214,214,000Source | -373,401,000Source | 234,118,000Source | -390,049,000Source | 229,680,000Source | -384,403,000Source |
| Liabilities and EquityUSD | 287,469,000Source | — | 328,222,000Source | 302,971,000Source | — | 302,798,000Source | — | 305,406,000Source | 150,892,000Source |
| Current liabilities: | |||||||||
| Liabilities, CurrentUSD | 70,123,000Source | — | 75,483,000Source | 57,988,000Source | — | 68,680,000Source | — | 75,726,000Source | 53,953,000Source |
| Operating Lease, Liability, CurrentUSD | 0Source | — | — | 0Source | — | — | — | 0Source | 415,000Source |
| Accounts Payable, CurrentUSD | 5,344,000Source | — | 11,804,000Source | 7,403,000Source | — | 8,100,000Source | — | 10,276,000Source | 4,168,000Source |
| Other Liabilities, NoncurrentUSD | 0Source | — | 0Source | 373,000Source | — | 0Source | — | 0Source | 285,000Source |
| Additional Financial Items | |||||||||
| Accrued Liabilities, CurrentUSD | 37,622,000Source | — | 35,978,000Source | 25,060,000Source | — | 31,227,000Source | — | 40,392,000Source | 29,840,000Source |
| Long-term DebtUSD | 0Source | — | — | 29,966,000Source | — | — | — | 0Source | 29,771,000Source |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 1,508,000Source | 1,333,000Source | 5,491,000Source | 4,803,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 4,209,000Source | 2,844,000Source | 12,955,000Source | 9,420,000Source |
| Changes in operating assets and liabilities: | ||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | 6,206,000Source | 6,496,000Source | 12,357,000Source | 8,805,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | -655,000Source | -254,000Source | 1,190,000Source | -318,000Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | -2,124,000Source | 283,000Source | 6,289,000Source | 399,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -11,834,000Source | -16,118,000Source | 18,252,000Source | -34,179,000Source |
| Cash flows from investing activities: | ||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -1,557,000Source | -1,249,000Source | -5,832,000Source | -3,863,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 78,000Source | 315,000Source | 1,322,000Source | 596,000Source |
| Cash flows from financing activities: | ||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 3,120,000Source | 372,000Source | 133,224,000Source | -1,209,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -10,271,000Source | -16,995,000Source | 145,644,000Source | -39,251,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 198,627,000Source | 83,735,000Source | 221,712,000Source | 223,146,000Source | 211,765,000Source | 59,397,000Source | 222,036,000Source | 76,392,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 18,000Source | 896,000Source | 2,420,000Source | 3,854,000Source |
| Additional Financial Items | ||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 3,536,000Source | 2,160,000Source | 5,631,000Source | 2,830,000Source | 4,209,000Source | 2,844,000Source | 12,955,000Source | 9,420,000Source |
| Amortization of Debt Issuance CostsUSD | — | — | — | — | — | — | 0Source | 109,000Source | 285,000Source | 389,000Source |
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | — | — | 1,900,000Source | 2,000,000Source |
| Capitalized Computer Software, AmortizationUSD | — | — | — | — | — | — | — | — | 3,000,000Source | 2,200,000Source |
| DepreciationUSD | — | — | — | — | — | — | — | — | 700,000Source | 600,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | — | — | — | — | -2,000Source | -1,000Source | -8,000Source | -2,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | -2,109,000Source | 0Source | — | — | — | — | -2,109,000Source | 0Source |
| General and Administrative ExpenseUSD | — | — | 14,340,000Source | 10,659,000Source | 15,725,000Source | 12,308,000Source | 13,990,000Source | 11,320,000Source | 52,184,000Source | 42,555,000Source |
| GoodwillUSD | — | — | 13,240,000Source | — | 13,240,000Source | 13,240,000Source | 13,240,000Source | — | 13,240,000Source | 13,240,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | 0Source | 0Source |
| Income Tax Expense (Benefit)USD | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| InterestExpenseNonoperatingUSD | — | — | 353,000Source | 1,147,000Source | 14,000Source | 1,094,000Source | 18,000Source | 1,074,000Source | 2,534,000Source | 4,506,000Source |
| Investment Income, InterestUSD | — | — | 2,009,000Source | 17,000Source | 1,759,000Source | 863,000Source | 1,829,000Source | 542,000Source | 5,305,000Source | 805,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -3,178,000Source | -9,226,000Source | 5,294,000Source | -5,311,000Source | -2,970,000Source | -9,448,000Source | -12,778,000Source | -47,137,000Source |
| Nonoperating Income (Expense)USD | — | — | -665,000Source | -702,000Source | 1,745,000Source | -967,000Source | 1,811,000Source | -1,052,000Source | -806,000Source | -3,483,000Source |
| Operating ExpensesUSD | — | — | 47,584,000Source | 37,086,000Source | 60,238,000Source | 44,650,000Source | 53,474,000Source | 40,296,000Source | 182,911,000Source | 146,531,000Source |
| Payments of Financing CostsUSD | — | — | — | — | — | — | — | — | 0Source | 0Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | 3,247,000Source | 919,000Source | 9,368,000Source | 3,329,000Source |
| Payment, Tax Withholding, Share-based Payment Arrangement | — | — | — | — | — | — | —Source | —Source | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 68,030,000Source | 45,515,000Source | 87,835,000Source | 61,371,000Source | 78,048,000Source | 54,963,000Source | 260,210,000Source | 169,800,000Source |
| Cost of Goods and Services Sold | — | — | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source |
| Operating Income (Loss)USD | — | — | -2,513,000Source | -8,524,000Source | 3,549,000Source | -4,344,000Source | -4,781,000Source | -8,396,000Source | -11,972,000Source | -43,654,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -3,178,000Source | -9,226,000Source | 5,294,000Source | -5,311,000Source | -2,970,000Source | -9,448,000Source | -12,778,000Source | -47,137,000Source |
| Income Tax Expense (Benefit)USD | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -3,178,000Source | -9,226,000Source | 5,294,000Source | -5,311,000Source | -2,970,000Source | -9,448,000Source | -12,778,000Source | -47,137,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.06Source | -1.18Source | 0.09Source | -0.24Source | -0.05Source | -1.15Source | -0.35Source | -6.11Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.06Source | -1.18Source | 0.08Source | -0.24Source | -0.05Source | -1.15Source | -0.35Source | -6.11Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 57,658,000Source | 7,788,000Source | 59,685,000Source | 21,971,000Source | 58,923,000Source | 8,241,000Source | 36,639,000Source | 7,721,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 57,658,000Source | 7,788,000Source | 63,947,000Source | 21,971,000Source | 58,923,000Source | 8,241,000Source | 36,639,000Source | 7,721,000Source |
| Interest Expense (non-operating)USD | — | — | 353,000Source | 1,147,000Source | 14,000Source | 1,094,000Source | 18,000Source | 1,074,000Source | 2,534,000Source | 4,506,000Source |
| Additional Financial Items | ||||||||||
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | — | — | 1,900,000Source | 2,000,000Source |
| Capitalized Computer Software, AmortizationUSD | — | — | — | — | — | — | — | — | 3,000,000Source | 2,200,000Source |
| General and Administrative ExpenseUSD | — | — | 14,340,000Source | 10,659,000Source | 15,725,000Source | 12,308,000Source | 13,990,000Source | 11,320,000Source | 52,184,000Source | 42,555,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | 0Source | 0Source |
| Gross ProfitUSD | — | — | 45,071,000Source | 28,562,000Source | 63,787,000Source | 40,306,000Source | 48,693,000Source | 31,900,000Source | 170,939,000Source | 102,877,000Source |
| Investment Income, InterestUSD | — | — | 2,009,000Source | 17,000Source | 1,759,000Source | 863,000Source | 1,829,000Source | 542,000Source | 5,305,000Source | 805,000Source |
| Marketing and Advertising ExpenseUSD | — | — | — | — | — | — | — | — | 600,000Source | 500,000Source |
| Nonoperating Income (Expense)USD | — | — | -665,000Source | -702,000Source | 1,745,000Source | -967,000Source | 1,811,000Source | -1,052,000Source | -806,000Source | -3,483,000Source |
| Operating ExpensesUSD | — | — | 47,584,000Source | 37,086,000Source | 60,238,000Source | 44,650,000Source | 53,474,000Source | 40,296,000Source | 182,911,000Source | 146,531,000Source |
| Research and Development ExpenseUSD | — | — | 10,301,000Source | 8,850,000Source | 14,625,000Source | 10,024,000Source | 12,697,000Source | 8,806,000Source | 40,683,000Source | 35,923,000Source |
| Selling and Marketing ExpenseUSD | — | — | 22,943,000Source | 17,577,000Source | 29,888,000Source | 22,318,000Source | 26,787,000Source | 20,170,000Source | 90,044,000Source | 68,053,000Source |
Filing attachments
ef20076322_ex99-1.htm · SCHEDULE 13G · 2026-06-23
Exhibit 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the shares of common stock, $0.001 par value per share, of Omada Health, Inc. shall be filed on behalf of each of the undersigned and that this Joint Filing Agreement shall be filed as an exhibit to such Schedule 13G. As contemplated by Section 13d-1(k)(1)(ii), no person shall be responsible for the completeness or accuracy of the information concerning the other p…
Read attachment ↗